Literature DB >> 15461208

Prevalence of pulmonary tuberculosis in Karachi central prison.

N A Rao1.   

Abstract

OBJECTIVE: To determine the extent of pulmonary tuberculosis among prisoners in Karachi central jail, so that strategy for targeted intervention can be planned.
METHOD: This prospective observational study was done at Karachi central prison from 7-2-2002 to 14-2-2002. A team of doctors, laboratory and x-ray technicians visited the central prison. Patients who had symptoms suggestive of pulmonary tuberculosis were included in the study. Their chest x-ray was taken in the jail and three "spot specimens" of sputum were collected for three consecutive days. The sputum specimens were processed at the laboratory of Ojha Institute of Chest Diseases, Karachi.
RESULTS: Out of 4870 prisoners, 79 (1.62%) were pulmonary tuberculosis suspects. All were male and their mean age was 32 (22-75) years. Sixteen suspects already diagnosed were on anti-tuberculosis treatment (ATT) while 11 suspects gave history of ATT in the past for incomplete duration varying from 3-4 weeks to 3 months either regularly or irregularly. Twenty-two (28%) suspects were not expectorating while fifty-seven (72%) submitted the sputum for AFB (Acid Fast Bacilli), of which only one was smear positive. Radiologically, 39 (49%) chest x-rays including those of 22 who were not expectorating were normal. Eight (10%) showed healed lesion. Thirty-two (40.5%) chest x-rays were suggestive of active pulmonary tuberculosis, so clinically and radiologically 32 prisoners were suffering from active pulmonary tuberculosis. The prevalence of active pulmonary tuberculosis in jail population determined by using the formula, number of persons with active TB in jail divided by the total number of persons booked into jail was 657 per 100,000, which is 3.75 times higher than general population.
CONCLUSION: Pulmonary tuberculosis is 3.75 times more common than general population in Karachi central prison and concrete efforts are needed to eradicate tuberculosis from this segment of population. The integration of provincial TB control program with that of jail health services is urgently required.

Entities:  

Mesh:

Year:  2004        PMID: 15461208

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  5 in total

1.  Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan.

Authors:  Abdul M Kazi; Sharaf A Shah; Cathy A Jenkins; Bryan E Shepherd; Sten H Vermund
Journal:  Int J Infect Dis       Date:  2010-03-01       Impact factor: 3.623

2.  Pulmonary tuberculosis and drug resistance in Dhaka central jail, the largest prison in Bangladesh.

Authors:  Sayera Banu; Arman Hossain; Mohammad Khaja Mafij Uddin; Muhammad Reaj Uddin; Tahmeed Ahmed; Razia Khatun; Asif Mujtaba Mahmud; Khurshid Alam Hyder; Afzalunnessa Binte Lutfor; Md Sirajul Karim; Khalequ Zaman; Md Ashraful Islam Khan; Pravat Chandra Barua; Stephen P Luby
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

Review 3.  Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis.

Authors:  Katharina Kranzer; Rein Mgj Houben; Judith R Glynn; Linda-Gail Bekker; Robin Wood; Stephen D Lawn
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

Review 4.  Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic.

Authors:  F Biadglegne; A C Rodloff; U Sack
Journal:  Epidemiol Infect       Date:  2014-11-07       Impact factor: 4.434

Review 5.  [Prevalence of tuberculosis in incarcerated populations: systematic review and meta-analysisPrevalencia de tuberculosis en la población privada de libertad: revisión sistemática y metanálisis].

Authors:  Tiago Ricardo Moreira; Aline Campos Lemos; Renata Maria Colodette; Andréia Patrícia Gomes; Rodrigo Siqueira Batista
Journal:  Rev Panam Salud Publica       Date:  2019-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.